Breaking News Instant updates and real-time market news.

FAII

Fortress Value Acquisition Corp. II

$12.12 /

+0.13 (+1.08%)

06:38
02/22/21
02/22
06:38
02/22/21
06:38

ATI Physical Therapy to become public through $2.5B FVAC II merger agreement

Fortress Value Acquisition Corp. II, a special purpose acquisition company, and ATI Physical Therapy, a portfolio company of Advent International, announced that they have entered into a definitive merger agreement. Upon closing of the transaction, the combined company will operate as ATI Physical Therapy and remain NYSE-listed under a new ticker symbol. The transaction is expected to close in Q2, subject to approval by FVAC II's stockholders and other customary closing conditions. ATI owns and operates nearly 900 physical therapy clinics across 25 states. The existing management team, led by CEO Labeed Diab, CFO Joe Jordan and COO Ray Wahl, will continue to lead the business, and Advent will remain ATI's largest stockholder. The combined company represents an enterprise value of approximately $2.5B at closing, or 14x 2022 estimated adjusted EBITDA. Cash proceeds raised will consist of FVAC II's cash in trust of $345M and a fully committed common stock PIPE of $300M at $10.00 per share from institutional investors. FVAC II has amended the terms of its founder equity. FVAC II's sponsor will defer 100% of its founder shares in accordance with the following vesting schedule: 33% at $12.00 per share, 33% at $14.00 per share and 33% at $16.00 per share. FVAC II's sponsor will also cancel 50% of private warrants. Advent and other existing common equity holders of ATI, including management, will remain 100% invested following the closing, rolling approximately $1.3B of investment holdings into equity of the combined company. ATI's preferred equity holders, including GCM Grosvenor, who has been a decade-long investor in ATI, will continue to be significant investors and are converting approximately $130M of existing stake into equity of the combined company. Cash proceeds will be used to pay down ATI's existing debt and remaining preferred equity, reducing leverage. Pro forma net debt to adjusted EBITDA ratio is expected to be reduced from 5.2x to 2.1x based on 2022 estimated adjusted EBITDA. ATI common equity holders, ATI preferred equity holders, FVAC II stockholders and PIPE investors are expected to own approximately 63%, 6%, 17% and 14%, respectively, of the outstanding common shares of the combined company immediately following the merger. The boards of both FVAC II and ATI have unanimously approved the proposed business combination, and, following such approval, ATI stockholders adopted the merger agreement. The transaction is expected to be completed in Q2, subject to, among other customary closing conditions, approval by FVAC II stockholders and FVAC II having minimum cash of $472.5M.

TODAY'S FREE FLY STORIES

Syndicate
Autohome announces 27.26M share offering of ordinary shares » 18:49
03/02/21
03/02
18:49
03/02/21
18:49
ATHM

Autohome

$118.01 /

+1.59 (+1.37%)

Autohome announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATHM Autohome
$118.01 /

+1.59 (+1.37%)

ATHM Autohome
$118.01 /

+1.59 (+1.37%)

02/03/21 Macquarie
Autohome price target raised to $109 from $95 at Macquarie
02/03/21 HSBC
Autohome price target raised to $137 from $113 at HSBC
02/03/21 Benchmark
Autohome upgraded to Buy from Hold at Benchmark
12/22/20 JPMorgan
Latest Georgia polling favors Republicans, says JPMorgan
ATHM Autohome
$118.01 /

+1.59 (+1.37%)

ATHM Autohome
$118.01 /

+1.59 (+1.37%)

Upgrade
Rapid7 upgraded to Overweight from Neutral at Piper Sandler » 18:43
03/02/21
03/02
18:43
03/02/21
18:43
RPD

Rapid7

$79.21 /

-2.07 (-2.55%)

Piper Sandler analyst Rob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPD Rapid7
$79.21 /

-2.07 (-2.55%)

RPD Rapid7
$79.21 /

-2.07 (-2.55%)

02/17/21 Stifel
Rapid7 resumed with a Buy at Stifel
02/10/21 Morgan Stanley
Morgan Stanley downgrades Qualys to Underweight on growth and margin pressures
02/10/21 RBC Capital
Rapid7 price target raised to $110 from $105 at RBC Capital
01/27/21 Truist
Rapid7 price target raised to $95 from $72 at Truist
RPD Rapid7
$79.21 /

-2.07 (-2.55%)

RPD Rapid7
$79.21 /

-2.07 (-2.55%)

Recommendations
Target price target lowered to $200 from $220 at Baird » 18:41
03/02/21
03/02
18:41
03/02/21
18:41
TGT

Target

$173.40 /

-12.72 (-6.83%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGT Target
$173.40 /

-12.72 (-6.83%)

TGT Target
$173.40 /

-12.72 (-6.83%)

02/09/21 Jefferies
Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Stifel
Target upgraded to Buy from Hold at Stifel
01/14/21 DA Davidson
Target price target raised to $229 from $208 at DA Davidson
TGT Target
$173.40 /

-12.72 (-6.83%)

TGT Target
$173.40 /

-12.72 (-6.83%)

TGT Target
$173.40 /

-12.72 (-6.83%)

TGT Target
$173.40 /

-12.72 (-6.83%)

Hot Stocks
Welltower and ProMedica announce partnership expansion » 18:41
03/02/21
03/02
18:41
03/02/21
18:41
WELL

Welltower

$68.68 /

+0.15 (+0.22%)

, GEN

Genesis Healthcare

$0.82 /

+0.0034 (+0.42%)

ProMedica and Welltower…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WELL Welltower
$68.68 /

+0.15 (+0.22%)

GEN Genesis Healthcare
$0.82 /

+0.0034 (+0.42%)

WELL Welltower
$68.68 /

+0.15 (+0.22%)

02/09/21 Mizuho
Welltower price target raised to $60 from $57 at Mizuho
01/26/21 Deutsche Bank
Welltower price target lowered to $67 from $71 at Deutsche Bank
01/11/21 BMO Capital
Brookdale data supports cautious view on senior housing, says BMO
01/07/21 BMO Capital
Welltower downgraded to Underperform from Market Perform at BMO Capital
GEN Genesis Healthcare
$0.82 /

+0.0034 (+0.42%)

01/25/21 Credit Suisse
Genesis Healthcare downgraded to Underperform from Neutral at Credit Suisse
08/11/20 Credit Suisse
Healthcare Services downgraded to Neutral from Outperform at Credit Suisse
WELL Welltower
$68.68 /

+0.15 (+0.22%)

Hot Stocks
Grocery Outlet sees FY21 EBITDA margins in line with 2019 performance » 18:36
03/02/21
03/02
18:36
03/02/21
18:36
GO

Grocery Outlet

$36.12 /

+0.19 (+0.53%)

Says first half of 2021…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

11/18/20 Berenberg
Grocery Outlet initiated with a Buy at Berenberg
11/11/20 DA Davidson
Grocery Outlet price target lowered to $50 from $53 at DA Davidson
08/14/20 DA Davidson
Grocery Outlet initiated with a Buy at DA Davidson
08/14/20 DA Davidson
Grocery Outlet initiated with a Buy at DA Davidson
GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

  • 13
    Aug
  • 23
    Apr
GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

Hot Stocks
Crown Castle chairman buys 7.8K shares of common stock » 18:30
03/02/21
03/02
18:30
03/02/21
18:30
CCI

Crown Castle

$153.18 /

-0.63 (-0.41%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCI Crown Castle
$153.18 /

-0.63 (-0.41%)

CCI Crown Castle
$153.18 /

-0.63 (-0.41%)

01/14/21 Citi
Crown Castle upgraded to Buy from Neutral at Citi
01/11/21 BofA
BofA US 1 List changes
01/04/21 LightShed Partners
Crown Castle initiated with a Buy at LightShed Partners
12/11/20 Deutsche Bank
Crown Castle upgraded to Buy from Hold at Deutsche Bank
CCI Crown Castle
$153.18 /

-0.63 (-0.41%)

CCI Crown Castle
$153.18 /

-0.63 (-0.41%)

CCI Crown Castle
$153.18 /

-0.63 (-0.41%)

Initiation
Certara initiated with an Overweight at Barclays » 18:28
03/02/21
03/02
18:28
03/02/21
18:28
CERT

Certara

$35.32 /

-0.72 (-2.00%)

Barclays analyst Luke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CERT Certara
$35.32 /

-0.72 (-2.00%)

16:32 Today Barclays
Certara initiated with an Overweight at Barclays
01/05/21 Morgan Stanley
Morgan Stanley starts Certara at Equal Weight, says fully valued
01/05/21 Morgan Stanley
Certara initiated with an Equal Weight at Morgan Stanley
01/05/21
Fly Intel: Top five analyst initiations
  • 11
    Dec
CERT Certara
$35.32 /

-0.72 (-2.00%)

CERT Certara
$35.32 /

-0.72 (-2.00%)

Initiation
Syneos Health initiated with an Equal Weight at Barclays » 18:25
03/02/21
03/02
18:25
03/02/21
18:25
SYNH

Syneos Health

$75.44 /

-0.79 (-1.04%)

Barclays analyst Luke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYNH Syneos Health
$75.44 /

-0.79 (-1.04%)

SYNH Syneos Health
$75.44 /

-0.79 (-1.04%)

16:36 Today Barclays
Syneos Health initiated with an Equal Weight at Barclays
02/22/21 Mizuho
Syneos Health price target raised to $87 from $72 at Mizuho
02/19/21 Citi
Syneos Health price target raised to $85 from $80 at Citi
12/09/20 JPMorgan
Syneos Health price target raised to $85 from $80 at JPMorgan
SYNH Syneos Health
$75.44 /

-0.79 (-1.04%)

  • 01
    Mar
  • 02
    Dec
  • 16
    Sep
SYNH Syneos Health
$75.44 /

-0.79 (-1.04%)

Initiation
PPD initiated with an Overweight at Barclays » 18:19
03/02/21
03/02
18:19
03/02/21
18:19
PPD

PPD

$36.00 /

+0.36 (+1.01%)

, ICLR

Icon

$172.19 /

-0.78 (-0.45%)

Barclays analyst Luke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPD PPD
$36.00 /

+0.36 (+1.01%)

ICLR Icon
$172.19 /

-0.78 (-0.45%)

PPD PPD
$36.00 /

+0.36 (+1.01%)

16:35 Today Barclays
PPD initiated with an Overweight at Barclays
02/25/21 Deutsche Bank
PPD price target raised to $39 from $38 at Deutsche Bank
02/25/21 Citi
PPD price target raised to $42 from $40 at Citi
10/29/20 Deutsche Bank
PPD price target raised to $38 from $33 at Deutsche Bank
ICLR Icon
$172.19 /

-0.78 (-0.45%)

18:08 Today Barclays
Icon initiated with an Equal Weight at Barclays
16:34 Today Barclays
Icon initiated with an Equal Weight at Barclays
03/01/21 UBS
Icon upgraded to Buy from Neutral at UBS
03/01/21 UBS
Icon upgraded to Buy from Neutral at UBS
PPD PPD
$36.00 /

+0.36 (+1.01%)

ICLR Icon
$172.19 /

-0.78 (-0.45%)

  • 17
    Sep
PPD PPD
$36.00 /

+0.36 (+1.01%)

ICLR Icon
$172.19 /

-0.78 (-0.45%)

Periodicals
GM-backed Cruise in talks to acquire Voyage, Bloomberg reports » 18:19
03/02/21
03/02
18:19
03/02/21
18:19
GM

General Motors

$54.12 /

+1.54 (+2.93%)

Cruise, the self-driving…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

02/19/21 Morgan Stanley
GM's 'hidden gems' drawing rising investor interest, says Morgan Stanley
02/18/21 Citi
General Motors price target raised to $85 from $70 at Citi
02/16/21 Wedbush
Wedbush expects Apple to announce formal EV partnership in 2021
02/11/21 RBC Capital
General Motors price target raised to $67 from $52 at RBC Capital
GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

Initiation
Iqvia initiated with an Overweight at Barclays » 18:13
03/02/21
03/02
18:13
03/02/21
18:13
IQV

Iqvia

$192.72 /

-1.69 (-0.87%)

Barclays analyst Luke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IQV Iqvia
$192.72 /

-1.69 (-0.87%)

IQV Iqvia
$192.72 /

-1.69 (-0.87%)

16:34 Today Barclays
Iqvia initiated with an Overweight at Barclays
02/11/21 Truist
Iqvia price target raised to $235 from $197 at Truist
02/11/21 Wells Fargo
Iqvia price target raised to $230 from $205 at Wells Fargo
02/11/21 Baird
Iqvia price target raised to $221 from $208 at Baird
IQV Iqvia
$192.72 /

-1.69 (-0.87%)

IQV Iqvia
$192.72 /

-1.69 (-0.87%)

IQV Iqvia
$192.72 /

-1.69 (-0.87%)

Initiation
Icon initiated with an Equal Weight at Barclays » 18:08
03/02/21
03/02
18:08
03/02/21
18:08
ICLR

Icon

$172.19 /

-0.78 (-0.45%)

, PRAH

PRA Health

$142.89 /

-1.13 (-0.78%)

Barclays analyst Luke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ICLR Icon
$172.19 /

-0.78 (-0.45%)

PRAH PRA Health
$142.89 /

-1.13 (-0.78%)

ICLR Icon
$172.19 /

-0.78 (-0.45%)

16:34 Today Barclays
Icon initiated with an Equal Weight at Barclays
03/01/21 UBS
Icon upgraded to Buy from Neutral at UBS
03/01/21 UBS
Icon upgraded to Buy from Neutral at UBS
02/26/21 Truist
Icon upgraded to Buy from Hold at Truist
PRAH PRA Health
$142.89 /

-1.13 (-0.78%)

03/01/21 UBS
Icon upgraded to Buy from Neutral at UBS
02/26/21 Truist
Icon upgraded to Buy from Hold at Truist
02/25/21 Jefferies
PRA Health downgraded to Hold from Buy at Jefferies
02/25/21 Deutsche Bank
Icon price target raised to $208 from $179 at Deutsche Bank
ICLR Icon
$172.19 /

-0.78 (-0.45%)

PRAH PRA Health
$142.89 /

-1.13 (-0.78%)

ICLR Icon
$172.19 /

-0.78 (-0.45%)

PRAH PRA Health
$142.89 /

-1.13 (-0.78%)

Periodicals
Goldman Sachs' general counsel, Karen Seymour, to leave, Bloomberg reports » 18:08
03/02/21
03/02
18:08
03/02/21
18:08
GS

Goldman Sachs

$330.86 /

+0.975 (+0.30%)

Karen Seymour, Goldman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$330.86 /

+0.975 (+0.30%)

GS Goldman Sachs
$330.86 /

+0.975 (+0.30%)

02/24/21 Wells Fargo
Goldman Sachs price target raised to $360 from $335 at Wells Fargo
01/28/21 Deutsche Bank
Goldman Sachs price target raised to $310 from $290 at Deutsche Bank
01/22/21 Citi
Goldman Sachs price target raised to $370 from $357 at Citi
01/20/21 Credit Suisse
Goldman Sachs price target raised to $345 from $325 at Credit Suisse
GS Goldman Sachs
$330.86 /

+0.975 (+0.30%)

GS Goldman Sachs
$330.86 /

+0.975 (+0.30%)

GS Goldman Sachs
$330.86 /

+0.975 (+0.30%)

GS Goldman Sachs
$330.86 /

+0.975 (+0.30%)

Periodicals
Biden's pick for SEC chief gives views on cryptocurrency oversight, Quarts says » 18:06
03/02/21
03/02
18:06
03/02/21
18:06
BTC

Bitcoin

$0.00 /

+ (+0.00%)

, BITCOIN

Bitcoin

$0.00 /

+ (+0.00%)

, GBTC

Bitcoin Investment Trust

$0.00 /

+ (+0.00%)

President Joe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTC Bitcoin
$0.00 /

+ (+0.00%)

BITCOIN Bitcoin
$0.00 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
BITCOIN Bitcoin
$0.00 /

+ (+0.00%)

GBTC Bitcoin Investment Trust
$0.00 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BITCOIN Bitcoin
$0.00 /

+ (+0.00%)

GBTC Bitcoin Investment Trust
$0.00 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BITCOIN Bitcoin
$0.00 /

+ (+0.00%)

Hot Stocks
Mayville Engineering not providing financial outlook for 2021 » 18:02
03/02/21
03/02
18:02
03/02/21
18:02
MEC

Mayville Engineering

$15.15 /

+0.44 (+2.99%)

Based on the ongoing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEC Mayville Engineering
$15.15 /

+0.44 (+2.99%)

MEC Mayville Engineering
$15.15 /

+0.44 (+2.99%)

02/04/21 Baird
Mayville Engineering price target raised to $20 from $14 at Baird
11/04/20 Citi
Mayville Engineering price target raised to $13 from $10 at Citi
08/21/20
Fly Intel: Top five analyst upgrades
08/21/20 UBS
Mayville Engineering upgraded to Buy from Neutral at UBS
MEC Mayville Engineering
$15.15 /

+0.44 (+2.99%)

Earnings
Mayville Engineering reports Q4 pro forma EPS 5c, consensus 1c » 18:02
03/02/21
03/02
18:02
03/02/21
18:02
MEC

Mayville Engineering

$15.15 /

+0.44 (+2.99%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEC Mayville Engineering
$15.15 /

+0.44 (+2.99%)

MEC Mayville Engineering
$15.15 /

+0.44 (+2.99%)

02/04/21 Baird
Mayville Engineering price target raised to $20 from $14 at Baird
11/04/20 Citi
Mayville Engineering price target raised to $13 from $10 at Citi
08/21/20
Fly Intel: Top five analyst upgrades
08/21/20 UBS
Mayville Engineering upgraded to Buy from Neutral at UBS
MEC Mayville Engineering
$15.15 /

+0.44 (+2.99%)

Initiation
Thermo Fisher initiated with an Overweight at Barclays » 18:01
03/02/21
03/02
18:01
03/02/21
18:01
TMO

Thermo Fisher

$462.24 /

+2.7 (+0.59%)

Barclays analyst Luke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TMO Thermo Fisher
$462.24 /

+2.7 (+0.59%)

TMO Thermo Fisher
$462.24 /

+2.7 (+0.59%)

16:36 Today Barclays
Thermo Fisher initiated with an Overweight at Barclays
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/03/21 BTIG
Thermo Fisher price target raised to $590 from $540 at BTIG
02/02/21 SVB Leerink
Thermo Fisher price target raised to $560 from $525 at SVB Leerink
TMO Thermo Fisher
$462.24 /

+2.7 (+0.59%)

TMO Thermo Fisher
$462.24 /

+2.7 (+0.59%)

TMO Thermo Fisher
$462.24 /

+2.7 (+0.59%)

Periodicals
GM-backed Cruise in talks to acquire Voyage, Bloomberg reports » 18:00
03/02/21
03/02
18:00
03/02/21
18:00
GM

General Motors

$54.12 /

+1.54 (+2.93%)

Cruise, the self-driving…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

02/19/21 Morgan Stanley
GM's 'hidden gems' drawing rising investor interest, says Morgan Stanley
02/18/21 Citi
General Motors price target raised to $85 from $70 at Citi
02/16/21 Wedbush
Wedbush expects Apple to announce formal EV partnership in 2021
02/11/21 RBC Capital
General Motors price target raised to $67 from $52 at RBC Capital
GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

GM General Motors
$54.12 /

+1.54 (+2.93%)

Initiation
Sotera Health initiated with an Overweight at Barclays » 17:53
03/02/21
03/02
17:53
03/02/21
17:53
SHC

Sotera Health

$26.62 /

-0.91 (-3.31%)

Barclays analyst Luke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHC Sotera Health
$26.62 /

-0.91 (-3.31%)

SHC Sotera Health
$26.62 /

-0.91 (-3.31%)

16:35 Today Barclays
Sotera Health initiated with an Overweight at Barclays
01/13/21 Baird
Sotera Health initiated with an Outperform at Baird
12/15/20 KeyBanc
Sotera Health initiated with an Overweight at KeyBanc
12/15/20 JPMorgan
Sotera Health initiated with an Overweight at JPMorgan
SHC Sotera Health
$26.62 /

-0.91 (-3.31%)

  • 20
    Nov
SHC Sotera Health
$26.62 /

-0.91 (-3.31%)

Initiation
Ortho Clinical Diagnostics initiated with an Overweight at Barclays » 17:46
03/02/21
03/02
17:46
03/02/21
17:46
OCDX

Ortho Clinical Diagnostics

$17.58 /

-0.02 (-0.11%)

Barclays analyst Luke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCDX Ortho Clinical Diagnostics
$17.58 /

-0.02 (-0.11%)

16:35 Today Barclays
Ortho Clinical Diagnostics initiated with an Overweight at Barclays
02/22/21
Fly Intel: Top five analyst initiations
02/22/21 Evercore ISI
Ortho Clinical Diagnostics initiated with an Outperform at Evercore ISI
02/22/21 Credit Suisse
Ortho Clinical Diagnostics initiated with an Outperform at Credit Suisse
  • 28
    Jan
OCDX Ortho Clinical Diagnostics
$17.58 /

-0.02 (-0.11%)

OCDX Ortho Clinical Diagnostics
$17.58 /

-0.02 (-0.11%)

Hot Stocks
Rio Tinto chairman Thompson to not seek re-election as board director » 17:45
03/02/21
03/02
17:45
03/02/21
17:45
RIO

Rio Tinto

$91.27 /

+1.43 (+1.59%)

Rio Tinto chairman Simon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RIO Rio Tinto
$91.27 /

+1.43 (+1.59%)

RIO Rio Tinto
$91.27 /

+1.43 (+1.59%)

02/18/21 UBS
Rio Tinto price target raised to 5,800 GBp from 5,500 GBp at UBS
02/09/21 JPMorgan
Rio Tinto price target raised to 7,120 GBp from 6,940 GBp at JPMorgan
02/08/21 JPMorgan
Rio Tinto price target lowered to 6,940 GBp from 7,000 GBp at JPMorgan
02/05/21
Fly Intel: Top five analyst initiations
RIO Rio Tinto
$91.27 /

+1.43 (+1.59%)

RIO Rio Tinto
$91.27 /

+1.43 (+1.59%)

Periodicals
Toyota does not plan to ask Texas workers to stop wearing masks, Reuters says » 17:44
03/02/21
03/02
17:44
03/02/21
17:44
TM

Toyota

$149.30 /

+0.025 (+0.02%)

Toyota currently does not…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TM Toyota
$149.30 /

+0.025 (+0.02%)

TM Toyota
$149.30 /

+0.025 (+0.02%)

09/14/20 Credit Suisse
Toyota upgraded to Outperform from Neutral at Credit Suisse
09/08/20 Bernstein
Bernstein sees Tesla's current valuation as 'mind-boggling'
07/29/20 Morgan Stanley
Tesla price target raised to $1,050 from $740 at Morgan Stanley
07/28/20 Macquarie
Toyota initiated with an Underperform at Macquarie
TM Toyota
$149.30 /

+0.025 (+0.02%)

TM Toyota
$149.30 /

+0.025 (+0.02%)

TM Toyota
$149.30 /

+0.025 (+0.02%)

Initiation
Illumina started with an Underweight at Barclays on near-term growth issues » 17:42
03/02/21
03/02
17:42
03/02/21
17:42
ILMN

Illumina

$441.51 /

-4.8 (-1.08%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$441.51 /

-4.8 (-1.08%)

ILMN Illumina
$441.51 /

-4.8 (-1.08%)

16:30 Today Barclays
Illumina initiated with an Underweight at Barclays
02/16/21 BTIG
Illumina price target raised to $570 from $410 at BTIG
02/12/21 Piper Sandler
Illumina price target raised to $510 from $415 at Piper Sandler
02/12/21 Cowen
Illumina price target raised to $460 from $385 at Cowen
ILMN Illumina
$441.51 /

-4.8 (-1.08%)

ILMN Illumina
$441.51 /

-4.8 (-1.08%)

ILMN Illumina
$441.51 /

-4.8 (-1.08%)

ILMN Illumina
$441.51 /

-4.8 (-1.08%)

Upgrade
Sensata upgraded to Overweight at JPMorgan on auto electrification/connectivity » 17:35
03/02/21
03/02
17:35
03/02/21
17:35
ST

Sensata

$59.66 /

+0.42 (+0.71%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ST Sensata
$59.66 /

+0.42 (+0.71%)

ST Sensata
$59.66 /

+0.42 (+0.71%)

16:59 Today JPMorgan
Sensata upgraded to Overweight from Neutral at JPMorgan
01/22/21 Barclays
Sensata price target raised to $65 from $55 at Barclays
12/14/20 Morgan Stanley
Sensata upgraded to Overweight on dollar content growth at Morgan Stanley
12/14/20 Morgan Stanley
Sensata upgraded to Overweight from Equal Weight at Morgan Stanley
ST Sensata
$59.66 /

+0.42 (+0.71%)

ST Sensata
$59.66 /

+0.42 (+0.71%)

Initiation
Danaher started at Overweight at Barclays on GE biopharma business potential » 17:29
03/02/21
03/02
17:29
03/02/21
17:29
DHR

Danaher

$224.05 /

-1.54 (-0.68%)

, GE

General Electric

$12.98 /

-0.135 (-1.03%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DHR Danaher
$224.05 /

-1.54 (-0.68%)

GE General Electric
$12.98 /

-0.135 (-1.03%)

DHR Danaher
$224.05 /

-1.54 (-0.68%)

16:33 Today Barclays
Danaher initiated with an Overweight at Barclays
01/06/21 Cowen
Danaher named a top diversified pick at Cowen
01/04/21 Evercore ISI
Danaher added to Core Ideas List at Evercore ISI
12/02/20 Goldman Sachs
Danaher initiated with a Buy at Goldman Sachs
GE General Electric
$12.98 /

-0.135 (-1.03%)

02/22/21 Goldman Sachs
General Electric price target raised to $15 at Goldman Sachs after meetings
01/28/21 Barclays
General Electric price target raised to $13 from $12 at Barclays
01/27/21 Morgan Stanley
General Electric price target raised to $13 from $12 at Morgan Stanley
01/27/21 Citi
General Electric developing track record of delivering, says Citi
DHR Danaher
$224.05 /

-1.54 (-0.68%)

GE General Electric
$12.98 /

-0.135 (-1.03%)

  • 08
    May
DHR Danaher
$224.05 /

-1.54 (-0.68%)

GE General Electric
$12.98 /

-0.135 (-1.03%)

GE General Electric
$12.98 /

-0.135 (-1.03%)

DHR Danaher
$224.05 /

-1.54 (-0.68%)

GE General Electric
$12.98 /

-0.135 (-1.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.